COX-2 inhibition does not alter wound healing outcomes of a volumetric muscle loss injury treated with a biologic scaffold.
RatOtherSprague-DawleyMaleAcute administration at the time of injury and scaffold implantation
Model: Surgically created volumetric muscle loss defect treated with an implanted biologic scaffold
Adjunct COX-2 inhibition with mavacoxib did not alter the baseline functional or histomorphological repair outcomes achieved by the biologic scaffold in volumetric muscle loss.
Extraction: extract · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.